Revance Therapeutics
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$382.61M
-2.1
-1.68
$237.08M
597
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The company is headquartered in Nashville, Tennessee and currently employs 597 full-time employees. The firm operates as a biotechnology company that develops, manufactures, and markets aesthetic and therapeutic products. The company offers products and services, such as DAXXIFY (DaxibotulinumtoxinA-lanm) and resilient hyaluronic acid (RHA) collection, includes aesthetics and therapeutics.
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The company is headquartered in Nashville, Tennessee and currently employs 597 full-time employees. The firm operates as a biotechnology company that develops, manufactures, and markets aesthetic and therapeutic products. The company offers products and services, such as DAXXIFY (DaxibotulinumtoxinA-lanm) and resilient hyaluronic acid (RHA) collection, includes aesthetics and therapeutics.
Recently from Cashu
Revance Therapeutics Gains FDA Approval for RHA® Dynamic Volume in Aesthetic Treatments
Revance Therapeutics and Teoxane Secure FDA Approval for RHA® Dynamic Volume Revance Therapeutics, in collaboration with Teoxane, celebrates a significant milestone with the recent FDA approval of RHA…
Revance Therapeutics Appoints Steve Kreider as Chief Revenue Officer to Drive Growth.
Revance Therapeutics Strengthens Leadership with New Chief Revenue Officer Revance Therapeutics, a prominent player in the aesthetics and skincare industry, makes a significant move by appointing Stev…
Revance Therapeutics Appoints Steve Kreider as Chief Revenue Officer to Boost Growth Strategies
Revance Therapeutics Strengthens Leadership with Appointment of Steve Kreider Revance Therapeutics, a prominent player in the aesthetics and skincare industry, has made a significant move by appointin…
Revance Therapeutics Appoints New Chief Revenue Officer to Enhance Growth in Aesthetics and Therapeutics
Revance Therapeutics Welcomes New Chief Revenue Officer to Drive Growth in Aesthetics and Therapeutics Revance Therapeutics, a prominent player in the aesthetics and skincare sector, announces the app…